Delaware's Employee Benefits Committee report says holding down drug prices will be difficult due to lack of transparency by Pharmaceutical Benefit Managers. In our partnership with Spotlight Delaware Delmarva Public Media's Don Rush talks with reporter Nick Stonesifer about the significance of the finding for the First State. The full interview can be heard on this Friday's Delmarva Today at noon on WSDL and WESM.
New Delaware Report: Little Prospect to Bring Down Drug Prices for State and Retired Employees
freestock.org
/
creative commons (https://commons.wikimedia.org/wiki/File:Pill_3.jpg)
